Emerging evidence suggests periodontitis may contribute to stroke risk via vascular inflammation and endothelial dysfunction, promoting atherothrombosis and atrial fibrillation. This review aims to synthesize the evidence on the presence of oral bacteria and their products in biological samples from stroke patients and assess their potential impact on stroke pathophysiology, clinical outcomes, and prognosis. We conducted a narrative review of epidemiological, serological, and molecular studies examining the presence of oral bacterial DNA, endotoxins and antibodies against oral pathogens in biological samples (blood, saliva and thrombi) from stroke patients. Seropositivity for periodontal pathogens in blood was associated with incident stroke, as well as with poorer prognosis. Oral bacterial DNA, mainly from Streptococcus spp. and Prevotella spp., was consistently detected in thrombi, whereas no DNA from classic periodontal pathogens was found. The presence of P. gingivalis antibodies in thrombi was associated with lower complete reperfusion rates, while Acinetobacter spp. and Enterobacteriaceae correlated with higher early adverse events and poorer prognosis. DNA detection was limited by low-biomass samples and methodological constraints. These findings support a potential link between periodontitis and ischemic stroke. However, further studies using improved molecular methods are needed to clarify underlying mechanisms and to assess the presence of periodontal pathogen DNA in thrombi.
20 April 2026 in International Journal of Dental Hygiene
Aim: To systematically review the evidence on the relationship between periodontal health interventions and the risk of first‐ever ischemic stroke. Materials and Methods: Search strategy included electronic and hand searching to January 2025. MEDLINE (OVID), EMBASE (OVID), SCOPUS, LILACS, Web of Science (WOS) and Cochrane Central Register of Controlled Trials (CENTRAL) were searched. Eligible studies included clinical trials and observational designs reporting on any periodontal health intervention and ischemic stroke. Screening and data extraction were performed independently and in duplicate. Meta‐analyses were conducted when appropriate. Results: Seven studies involving 1,886,947 participants met the inclusion criteria from an initial set of 634 records. In a random‐effects meta‐analysis, periodontal interventions were associated with a lower risk of ischemic stroke (HR: 0.88 [0.81–0.95]). Tooth scaling, in particular, was associated with a reduced risk (HR: 0.84 [0.76–0.92]). Conclusion: Periodontal health interventions—especially tooth scaling—appear to be associated with a lower risk of ischemic stroke. These findings suggest a potential role for periodontal care in stroke prevention. Trial Registration: PROSPERO number: CRD42023450471